2745060-92-6
Chemical Structure
INX-315
- CAS No.: 2745060-92-6
- Formula:C19H21N7O3S
- Molecular Weight:427.48
InChIKey: KGJVKYSVVOQPDL-UHFFFAOYSA-N
SMILES: O=C(NN1)C2(CCCCC2)N(C1=C3)C4=C3C=NC(NC5=CC=C(S(=O)(N)=O)C=C5)=N4
Biological Activity: INX-315 is an orally active and selective CDK2 inhibitor that induces cell cycle arrest in the G1 phase. INX-315 reduces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in xenograft mouse models. INX-315 may be used in cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
INX-315 | 99.75% | INX-315 is an orally active and selective CDK2 inhibitor that induces cell cycle arrest in the G1 phase. INX-315 reduces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in xenograft mouse models. INX-315 may be used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords